World
-
International
8/6/2020 4:58:59 PM
|
World
-
International
7/29/2020 6:55:10 PM
|
World
-
International
7/29/2020 6:42:04 PM
|
World
-
International
7/29/2020 4:25:19 PM
|
World
-
International
7/28/2020 4:14:34 PM
Trump returned to his earlier advocacy for hydroxychloroquine after returning from a trip to North Carolina Monday where he promoted efforts to develop a COVID-19 vaccine
|
World
-
International
7/28/2020 1:03:46 PM
'I'm going to reveal something undercover: I am injected with one of the vaccines,' Gao Fu said in a webinar Sunday. 'I hope it will work,' he added
|
World
-
International
7/25/2020 4:34:06 PM
|
Business
-
Economy
7/24/2020 12:42:00 PM
Egypt’s tourism sector is coming back to life after being hit hard by the Covid-19 pandemic
|
Egypt
-
Politics
7/23/2020 9:47:53 PM
President Abdel-Fattah El Sisi has instructed the government to get hold of the vaccine once it becomes available
|
World
-
International
7/22/2020 3:25:28 PM
|
World
-
International
7/21/2020 9:08:17 AM
'The end of the year target for getting vaccine rollout, it's a possibility but there's absolutely no certainty about that because we need three things to happen'
|
Egypt
-
Politics
7/20/2020 6:31:26 PM
|
World
-
International
7/20/2020 3:59:49 PM
British researchers first began testing the vaccine in April in about 1,000 people, half of whom got the experimental vaccine
|
World
-
International
7/20/2020 1:40:48 PM
British officials say they have signed a deal to buy 90 million doses of experimental coronavirus vaccines being developed by the pharmaceutical giant Pfizer and others
|
World
-
International
7/20/2020 12:50:30 PM
Sinovac has been looking for volunteers outside China as the number of coronavirus cases there has dwindled, said a member of Bangladesh’s national technical advisory committee to tackle COVID-19
|
World
-
International
7/19/2020 5:20:37 PM
|
World
-
International
7/17/2020 2:51:53 PM
|
World
-
Africa
7/16/2020 10:18:03 PM
|
World
-
International
7/16/2020 6:25:01 PM
|
World
-
International
7/16/2020 12:16:49 PM
The first human trial of the vaccine, a month-long test on 38 people, ended this week. Researchers concluded that it is safe for use and induces an immune response, though the strength of that response is as yet unclear
|